Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apollo Endosurgery Inc (NASDAQ:APEN)

6.75
Delayed Data
As of Jul 26
 -0.20 / -2.88%
Today’s Change
4.96
Today|||52-Week Range
22.28
-44.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues9.2K23.8K15.4M14.6M
 
 
 
 
 
Cost of Goods Sold----2.3M4.5M
 
 
 
Depreciation And Amortization626.9K--9.0M2.4M
 
 
 
 
 
Operating ExpensesGross Income----4.1M7.7M
 
 
 
General Expenses2.0M2.1M9.6M14.5M
 
 
 
 
 
Research And Development935.6K538.1K2.6M2.0M
 
 
 
 
 
Total Operating Expenses2.7M2.1M20.8M21.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-2.0M-5.5M-6.8M
 
 
 
 
 
Extraordinary Charge0.00-1.7M-2.3M0.00
 
 
 
Interest Expense On Debt0.000.0011.3M1.5M
 
 
 
Other Expenses0.0013.00-480.0K125.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.7M-3.7M-19.5M-8.2M
 
 
 
 
 
Income Taxes0.000.00-191.0K-50.0K
 
 
 
Net Income-2.7M-3.7M-19.7M-8.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS434.7K436.1K563.1K10.7M
 
 
 
 
 
Shares To Calculate EPS Diluted434.7K436.1K563.1K10.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.11-$8.47-$35.01-$0.77
 
 
 
 
 
EPS Diluted-$6.11-$8.47-$35.01-$0.77